Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Huma Raises $130 Million Financing to Scale its Digital Health Platform for Better Care and Research
Huma Therapeutics Limited today announces the completion of its latest funding round with financing of approximately […]
Gracell Biotechnologies Appoints Dr. Yajin Ni as CTO
Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to developing highly […]
Grand Rounds and Doctor On Demand to Merge, Creating First of its Kind Patient-Centric Integrated Virtual Healthcare Company
Grand Rounds, a leader in healthcare quality and navigation, and Doctor On Demand, the nation’s […]
Abingworth Raises $582 Million for New Clinical Co-development Fund – ACCD 2
Abingworth, a leading international life sciences investment group, today announced the final closing of its […]
Collective Health Secures $280 Million to Accelerate the Digital Transformation of Healthcare
Health technology company Collective Health today announced it secured $280 million in funding in a […]
Vida Health Raises $110m in Series D Round Led by General Atlantic, Centene, and Axa Venture Partners
Virtual chronic care platform Vida Health announced today that it raised $110M in its Series […]
Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases
Alebund Pharmaceuticals (“Alebund” or the “Company”), a biopharmaceutical company dedicated to developing innovative therapies for […]
Bayer Foundation Supports Scientists in Sub-saharan Africa
Bayer Foundation and Alexander von Humboldt Foundation are expanding their existing cooperation. Bayer Foundation provides […]
Exelixis Acquires GamaMabs AMHR2
Exelixis, Inc. (Nasdaq: EXEL) and GamaMabs Pharma SA today announced that they have entered into an […]
Clean Biologics SAS acquires Biodextris Inc.
Clean Biologics, a group providing services to the biopharmaceutical industry, today announces the acquisition of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more